Replies to post #4881 on CytoSorbents Corporation (CTSO)

[vinovista]

I'm expecting sales for cytosorb division for the fourth quarter to come in around 250,000 based on the third quarter sales figure of 204,000. I'm more interested in the first quarter sales results though.
CTSO

[BuyMyAsk]

I have some thoughts.

I think Dr. Chan needs to get us some real news. He can't reiterate what he wrote in the SHL because everyonehas already traded off of that and taken that into consideration with the stock being priced at $0.20.

We need really good sales #, and FDA update and maybe an update on clinical data being published. At the end of the day we still do not know if this works for Sepsis. Lowering cytokines is great but does it save lives or reduce ICU costs? That is the $1B question. Chances are they don't have that data yet and that is why there has been no mention of it.

KOLs, partnership, news of uplisting, ETC - this is all a bunch of smoke in mirrors to keep the PPS elevated.